Table 3. Characteristics of all drug responses.
Panel A. Drug class | Total N (%)a | Correct Match N (%) | Incorrect Match N (%) | Indeterminate N (%) | P-value |
Analgesic | 3,393 (36.6) | 3,226 (95.1) | 53 (1.6) | 114 (3.4) | < .0001 |
Antacid | 35 (0.4) | 25 (71.4) | 6 (17.1) | 4 (11.4) | |
Anti-asthmatic | 15 (0.2) | 13 (86.7) | 1 (6.7) | 1 (6.7) | |
Anti-diabetic | 31 (0.3) | 23 (74.2) | 3 (9.7) | 5 (16.1) | |
Antihistamines | 120 (1.3) | 28 (23.3) | 43 (35.8) | 49 (40.8) | |
Anti-hypertensive | 334 (3.6) | 293 (87.7) | 25 (7.5) | 16 (4.8) | |
Anti-malarial | 462 (5.0) | 444 (96.1) | 15 (3.3) | 3 (0.7) | |
Anti-spasmodic | 19 (0.2) | 14 (73.7) | 4 (21.1) | 1 (5.3) | |
Antibiotics | 692 (7.5) | 443 (64.0) | 184 (26.6) | 65 (9.4) | |
Expectorant | 72 (0.8) | 47 (65.3) | 23 (31.9) | 2 (2.8) | |
Haematinics | 1,276 (13.8) | 651 (51.0) | 237 (18.6) | 388 (30.4) | |
Herbal | 1,297 (14.0) | 0 (0) | 0 (0) | 1,297 (100.0) | |
Vitamins and minerals | 1,520 (16.4) | 460 (30.3) | 511 (33.6) | 549 (36.1) | |
Total | 9,266 (100.0) | 5,667 (61.2) | 1,105 (11.9) | 2,494 (26.9) | |
Panel B. Place where drug was obtained | |||||
Public clinic | 366 (4.0) | 242 (66.1) | 58 (15.9) | 66 (18.0) | < .0001 |
Private clinic | 597 (6.5) | 409 (68.5) | 80 (13.4) | 108 (18.1) | |
Patent Proprietary Medicine Vendors (PPMVs) | 6,695 (73.0) | 4,796 (71.6) | 892 (13.3) | 1,007 (15.0) | |
Other | 1,514 (16.5) | 155 (10.2) | 58 (3.8) | 1,301 (85.9) | |
Total | 9,172 (100.0) | 5,602 (61.1) | 1,088 (11.9) | 2,482 (27.1) | |
Missing | 94 | 65 | 17 | 12 |
aValue represents percentage of the total number of drugs.